Integra LifeSciences Holdings Corporation Stock
Integra LifeSciences Holdings Corporation Stock price
Key metrics
Is Integra LifeSciences Holdings Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
Integra LifeSciences Holdings Corporation Stock Analysis
Analyst Opinions
18 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:
Analyst Opinions
18 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:
Financial data from Integra LifeSciences Holdings Corporation
| Mar '25 |
+/-
%
|
||
| Revenue | 1,624 1,624 |
6%
6%
|
|
| Gross Profit | 950 950 |
0%
0%
|
|
| EBITDA | 183 183 |
31%
31%
|
EBIT (Operating Income) EBIT | 168 168 |
33%
33%
|
| Net Profit | -29 -29 |
172%
172%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Integra LifeSciences Holdings Corporation directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Integra LifeSciences Holdings Corporation Stock News
Company Profile
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
| Head office | United States |
| CEO | Mojdeh Poul |
| Employees | 4,396 |
| Founded | 1989 |
| Website | www.integralife.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
